Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Amortizatization of Intangibles: 2011-2025

Historic Amortizatization of Intangibles for Niagen Bioscience (NAGE) over the last 12 years, with Sep 2025 value amounting to $38,000.

  • Niagen Bioscience's Amortizatization of Intangibles changed negligibly% to $38,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $151,000, marking a year-over-year increase of 160.64%. This contributed to the annual value of $151,000 for FY2024, which is 4.43% down from last year.
  • As of Q3 2025, Niagen Bioscience's Amortizatization of Intangibles stood at $38,000, which was down 0.00% from $38,000 recorded in Q2 2025.
  • In the past 5 years, Niagen Bioscience's Amortizatization of Intangibles registered a high of $299,000 during Q1 2022, and its lowest value of -$362,000 during Q4 2023.
  • Its 3-year average for Amortizatization of Intangibles is $38,364, with a median of $38,000 in 2025.
  • In the last 5 years, Niagen Bioscience's Amortizatization of Intangibles skyrocketed by 137.30% in 2022 and then slumped by 289.53% in 2023.
  • Over the past 5 years, Niagen Bioscience's Amortizatization of Intangibles (Quarterly) stood at $126,000 in 2021, then soared by 51.59% to $191,000 in 2022, then plummeted by 289.53% to -$362,000 in 2023, then skyrocketed by 110.50% to $38,000 in 2024, then remained steady at $38,000 in 2025.
  • Its Amortizatization of Intangibles stands at $38,000 for Q3 2025, versus $38,000 for Q2 2025 and $37,000 for Q1 2025.